Quadrature Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Buy
114,289
+69,220
+154% +$10.6M 0.21% 109
2025
Q4
$6.21M Buy
+45,069
New +$5.9M 0.06% 192
2016
Q4
Sell
-42,962
Closed -$3.04M 741
2016
Q3
$3.04M Buy
+42,962
New +$3.13M 0.26% 95
2016
Q2
Sell
-177,961
Closed -$11.6M 615
2016
Q1
$11.6M Buy
+177,961
New +$12.1M 1.6% 10
2015
Q3
Sell
-12,946
Closed -$1.14M 307
2015
Q2
$1.14M Buy
+12,946
New +$1.19M 1.03% 32

Other funds holding NVS

Quadrature Capital's NVS Position: Q1 2026 in Review

Quadrature Capital increased its Novartis (NVS) stake by 154% in Q1 2026, buying an estimated $10.6M and bringing the position to 114,289 shares worth $17.5M. The position accounts for 0.21% of the portfolio, ranked #109.

Quadrature Capital first reported a position in NVS in Q2 2015 and has held it in 5 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Quadrature Capital held 114,289 shares of Novartis worth $17.5M as of Q1 2026.
  • Quadrature Capital bought 69,220 Novartis shares in Q1 2026, an estimated $10.6M.
  • Novartis made up 0.21% of Quadrature Capital's portfolio in Q1 2026, its #109 holding.
  • Quadrature Capital first reported a position in Novartis in Q2 2015 and has held it in 5 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.